Why the study?
Unequivocal evidence has emerged of the causal role of fine particulate matter air pollution (PM2.5) in cardiovascular disease, motivating a summary of personal-level strategies to reduce its adverse effects.
Population
Individuals exposed to fine particulate matter air pollution (PM2.5), including those in heavily polluted countries, high-risk individuals, and travelers
Comparison
Personal-level protective actions versus no intervention or ineffective measures
Design
Scientific statement from the American Heart Association summarizing current evidence and expert consensus
Authors
Loading...
May support individualized PM2.5 exposure counseling; leaves open efficacy of specific interventions on cardiovascular outcomes.
This AHA scientific statement provides expert consensus on practical, personal-level strategies to mitigate the adverse cardiovascular effects of fine particulate matter air pollution.
Rajagopalan et al. (2020) conducted a review in Cardiovascular disease related to fine particulate matter (PM2.5) exposure. Personal-level protective actions against PM2.5 exposure was evaluated. This American Heart Association scientific statement provides expert consensus on personal-level strategies to prevent the adverse cardiovascular effects of fine particulate matter (PM2.5) exposure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: